Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: twt who wrote (493)	11/10/1998 6:53:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 2539

twt, they are different compounds, but both drugs interfere with the production of the enzyme, cyclooxygensase-2, linked to pain and swelling, without blocking the action of a related one, cyclooxygenase-1, or Cox-1, hence they are called Cox-2 inhibitors. They treat the same symptoms. Once-a-day vs twice-a-day, I guess we'll see whether that affects the sales. Many people are already taking other drugs twice a day, they may prefer the twice-a-day Celebrex.